FindTrial
Sign In

Efficacy of Nishalauha and Ferrous Sulphate in the management of Pandu.

A comparative clinical study to evaluate the effect of " Nishalauha with Ferrous Sulphate" in the management of Pandu w. s. r. to Iron Deficiency Anaemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034760
Enrollment
40
Registered
2021-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

Intervention1: Nishalauha: Tablet form, dose is 500mg OD for 30 days. Control Intervention1: Ferrous sulphate: 200mg tablet OD for 30 days.

Sponsors

Principal RGGPG Ayurvedic college and Hospital Paprola Kangra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having Hemoglobin level 8 to 11 gm%. Patients of either sex between 12 to 60 years. Blood picture presenting either Microcytic Hypochromic or Normocytic Hypochromic anaemia. In pregnancy after 1st trimester.

Exclusion criteria

Exclusion criteria: Patients having hemoglobin level less than 8 gm% and more than 11 gm%. IDA resulting from acute or chronic blood loss. Patients showing allergy to the trial drug. Sideroblastic anaemia, thalassemia major and minor. Anaemia in association with other systemic disorders which interferes with the prognosis and treatment of the case.

Design outcomes

Primary

MeasureTime frame
Fulfilment of objective and subjective criteria.Timepoint: 30 days—

Secondary

MeasureTime frame
General feeling of wellbeing. Restoration of the health.Timepoint: 30 days—

Countries

India

Contacts

Public ContactAjay Kumar

Rajiv Gandhi Govt PG College and Hospital Paprola Kangra HP

drrkmanglesh@gmail.com9816324204

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026